Literature DB >> 25595254

Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study.

Izabela Guimarães Barbosa1, David Henrique Rodrigues2, Natália Pessoa Rocha3, Larissa Fonseca da Cunha Sousa3, Erica Leandro M Vieira3, Ana Cristina Simões-E-Silva4, Arthur Kummer5, Antônio Lúcio Teixeira6.   

Abstract

The pathogenesis of autism spectrum disorder (ASD) is unknown, and the immune system has been appointed to play an important role. The interleukin 33 (IL-33), a member of the IL-1, may act as an alarmin. This study aimed to evaluate plasma levels of IL-33, sST2, and IL-1β in 30 patients with ASD in comparison with 18 controls matched by gender, age and maternal age at childbirth. Patients did not differ from controls in IL-33, sST2, and IL-1β plasma levels. Alarmin levels were not correlated with age, and neither was influenced by clinical parameters. Our results undermine the role of IL-33/ST2 in ASD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism; Cytokines; IL-1β; IL-33; sST2

Mesh:

Substances:

Year:  2014        PMID: 25595254     DOI: 10.1016/j.jneuroim.2014.11.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 2.  Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions.

Authors:  Karen Fairlie-Clarke; Mark Barbour; Chelsey Wilson; Shehla U Hridi; Debbie Allan; Hui-Rong Jiang
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

Review 3.  Do Alarmins Have a Potential Role in Autism Spectrum Disorders Pathogenesis and Progression?

Authors:  Eleonora Di Salvo; Marco Casciaro; Sebastiano Quartuccio; Lucrezia Genovese; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2018-12-20

Review 4.  IL-33 in Mental Disorders.

Authors:  Gianluca Pandolfo; Giovanni Genovese; Marco Casciaro; Maria Rosaria Anna Muscatello; Antonio Bruno; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Medicina (Kaunas)       Date:  2021-03-26       Impact factor: 2.430

Review 5.  Stress System Activation in Children and Adolescents With Autism Spectrum Disorder.

Authors:  Gerasimos Makris; Agorastos Agorastos; George P Chrousos; Panagiota Pervanidou
Journal:  Front Neurosci       Date:  2022-01-13       Impact factor: 4.677

6.  In search of immune cellular sources of abnormal cytokines in the blood in autism spectrum disorder: A systematic review of case-control studies.

Authors:  Wared Nour-Eldine; Samia M Ltaief; Nimshitha P Abdul Manaph; Abeer R Al-Shammari
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

Review 7.  Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.

Authors:  Yun Sun; Yankai Wen; Luxi Wang; Liang Wen; Wendong You; Shuang Wei; Lin Mao; Hao Wang; Zuobing Chen; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

8.  Association of Peripheral Blood Levels of Cytokines With Autism Spectrum Disorder: A Meta-Analysis.

Authors:  Huaying Zhao; Hongqi Zhang; Shijie Liu; Wulin Luo; Yongfeng Jiang; Junwei Gao
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.